José Luis Ferreiro: After Stent Treatment in Heart Attack Patients How to Balance Bleeding and Clotting Risk
José Luis Ferreiro, Head of the Department of Cardiology at Hospital Universitari Joan XXIII, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Happy to share this new Clinical Consensus Statement led by the ESC Working Group on Thrombosis in collaboration with ACCA, EAPCI and Working Group on Cardiovascular Pharmacotherapy
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention
Discussing alternative antithrombotic strategies to standard DAPT to reduce bleeding (DAPT abbreviation and de-escalation) or ischaemic (prolonged DAT) risk and some guidance to individualize therapy.”
Erik Lerkevang Grove, Cardiologist at Aarhus University Hospital, Skejby shared this post on LinkedIn, adding:
”Proud to be part of this important and comprehensive consensus document:
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention.”
Title: Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks: A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
Authors: Diana A Gorog, Jurrien M ten Berg, Gianluca Campo, Tobias Geisler, Bruna Gigante, Erik L Grove, Sigrun Halvorsen, Kurt Huber, Young-Hoon Jeong, Gregory Y H Lip, Eliano P Navarese, Andrea Rubboli, Jolanta M Siller Matula, Robert F Storey, Marco Valgimigli, Christophe Vandenbriele, Gemma Vilahur, Ingo Ahrens, Jose Luis Ferreiro
Read the Full Article on European Heart Journal Acute Cardiovascular Care
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests